Atrial fibrillation - PubMed

5 days ago

Atrial fibrillation affects approximately 37.6 million people worldwide, with prevalence expected to double in the next 35 years.
Wearable devices and diagnostic algorithms are increasing detection rates among the general public.
Atrial fibrillation increases the risk of stroke, thromboembolism, heart failure, and death, and reduces quality of life.
Patients often have comorbidities, complicating management due to accumulated risk factors and age.
Clinical guidelines emphasize stroke prevention, symptom relief, risk factor identification, and integrated care approaches.
Oral anticoagulation is the default for stroke prevention, and catheter ablation is now considered an initial treatment option for symptom relief.
Early identification and management of risk factors are crucial for optimizing care.
Patient-centered care and improved health literacy empower patients to take an active role in managing their condition.

Hasty Briefsbeta